Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IEFA vs GSK✓SelectedUSD · GSKIEFA vs GSK performance historyLatest closeAs of-1.51%11/19
Stock and ETF performance explorer

IEFA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+188.9%
GSK return
+111.8%
Excess return
+77.1%
Maximum drawdown
-34.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%+0.1%-0.9%
7D-5.0%-4.7%-0.2%-3.2%
30D-4.9%-4.7%-0.2%-3.2%
3M-8.5%-8.8%+0.3%-5.4%
6M-2.0%-4.6%+2.6%-0.9%
YTD+4.5%+1.0%+3.5%+2.6%
1Y+10.5%+6.9%+3.6%+5.9%
3Y+51.7%+52.5%-0.8%+20.7%
5Y+42.1%+40.3%+1.8%+15.1%
10Y+137.6%+99.0%+38.7%+56.6%
All+188.9%+111.8%+77.1%+80.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling